Wu Pei, Ocak Pinar Eser, Wang Dianhong, Ocak Umut, Xu Shancai, Li Yuchen, Zhang Tongyu, Shi Huaizhang
Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Loma Linda University School of Medicine, Loma Linda, California,.
J Stroke Cerebrovasc Dis. 2019 Feb;28(2):330-337. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.052. Epub 2018 Nov 2.
Ruptured tiny intracranial aneurysms (TIAs) have been challenging both for endovascular and neurosurgical interventions. Thus, we aimed to evaluate the safety and efficacy of low-profile visualized intraluminal support (LVIS) device in the treatment of ruptured TIAs (rTIAs).
Among 761 intracranial aneurysms which were treated either surgically or endovascularly, 32 rTIAs underwent stent-assisted coiling with LVIS device between 2014 and 2017. Patient data were reviewed retrospectively. Clinical and radiological outcomes were recorded at discharge and mid-term follow-up.
Mean patient ages were 53 ± 14.5 years. Mean aneurysm size was 2.28 ± .53 mm (range, 1-2.9 mm) with a mean dome:neck ratio of 1.08 (range, .75-2.14). The LVIS stents were successfully implanted in all patients. Mean follow-up period was 9.3 ± 1.9 months (range, 6-15 months). Immediate angiographic evaluation demonstrated complete occlusion in 13 (40.6%) patients, while neck remnant and residual sac were observed in 12 (37.5%) and 7 (21.9%), respectively. All patients had moderate disability (mRS 2-3) at discharge. Number of aneurysms with complete occlusion significantly increased and 82.1% of the patients (23 of 28) demonstrated complete occlusion at follow-up (P = .0015). Among these, 27 had good outcome (mRS 0-1; 96.9%) with significant improvement compared to discharge (P = .0001). There was no recurrence or enlargement of the residual aneurysms. Additionally, there were no procedure-related complications except the one (3.6%) showing asymptomatic stenosis of the posterior cerebral artery in follow-up imagings.
Stent-assisted coiling of rTIAs with LVIS device provides high rates of technical success and complete occlusion at mid-term follow-up with an excellent safety profile.
破裂的微小颅内动脉瘤(TIAs)对血管内介入和神经外科手术干预来说都是挑战。因此,我们旨在评估低轮廓可视化腔内支撑(LVIS)装置治疗破裂微小颅内动脉瘤(rTIAs)的安全性和有效性。
在761例接受手术或血管内治疗的颅内动脉瘤患者中,2014年至2017年间,32例rTIAs患者采用LVIS装置辅助弹簧圈栓塞治疗。对患者数据进行回顾性分析。在出院时和中期随访时记录临床和影像学结果。
患者平均年龄为53±14.5岁。动脉瘤平均大小为2.28±0.53mm(范围1 - 2.9mm),平均瘤顶与瘤颈比为1.08(范围0.75 - 2.14)。所有患者LVIS支架均成功植入。平均随访时间为9.3±1.9个月(范围6 - 15个月)。即刻血管造影评估显示13例(40.6%)患者完全闭塞,12例(37.5%)可见瘤颈残留,7例(21.9%)可见残留瘤囊。所有患者出院时均有中度残疾(mRS 2 - 3)。完全闭塞的动脉瘤数量显著增加,随访时82.1%的患者(28例中的23例)实现完全闭塞(P = 0.0015)。其中,27例预后良好(mRS 0 - 1;96.9%),与出院时相比有显著改善(P = 0.0001)。残留动脉瘤无复发或增大。此外,除1例(3.6%)在随访影像中显示大脑后动脉无症状狭窄外,无手术相关并发症。
采用LVIS装置对rTIAs进行支架辅助弹簧圈栓塞在中期随访时技术成功率高、完全闭塞率高且安全性良好。